Douglas Emmett (NYSE:DEI – Get Free Report) released its earnings results on Tuesday. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.44, Zacks reports. Douglas Emmett had a negative net margin of 1.68% and a negative return on equity of 0.43%.
Douglas Emmett Price Performance
Shares of Douglas Emmett stock traded down $0.15 during trading on Tuesday, hitting $17.91. 1,709,881 shares of the company were exchanged, compared to its average volume of 1,869,022. The firm has a 50 day moving average price of $18.46 and a 200 day moving average price of $17.43. The stock has a market capitalization of $3.00 billion, a price-to-earnings ratio of -179.05 and a beta of 1.11. The company has a quick ratio of 4.09, a current ratio of 4.09 and a debt-to-equity ratio of 1.51. Douglas Emmett has a fifty-two week low of $12.35 and a fifty-two week high of $20.50.
Douglas Emmett Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were paid a dividend of $0.19 per share. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 4.24%. Douglas Emmett’s dividend payout ratio (DPR) is -760.00%.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on DEI
Douglas Emmett Company Profile
Douglas Emmett, Inc (DEI) is a fully integrated, self-administered and self-managed real estate investment trust (REIT), and one of the largest owners and operators of high-quality office and multifamily properties located in the premier coastal submarkets of Los Angeles and Honolulu. Douglas Emmett focuses on owning and acquiring a substantial share of top-tier office properties and premier multifamily communities in neighborhoods that possess significant supply constraints, high-end executive housing and key lifestyle amenities.
Read More
- Five stocks we like better than Douglas Emmett
- 3 Healthcare Dividend Stocks to Buy
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Evaluate a Stock Before Buying
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- 5 Top Rated Dividend Stocks to Consider
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Douglas Emmett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Douglas Emmett and related companies with MarketBeat.com's FREE daily email newsletter.